+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Review of hematological indices of cancer patients receiving combined chemotherapy & radiotherapy or receiving radiotherapy alone

Review of hematological indices of cancer patients receiving combined chemotherapy & radiotherapy or receiving radiotherapy alone

Critical Reviews in Oncology/Hematology 105: 145-155

We observed the outcomes of chemotherapy with radiotherapy (CR) or radiotherapy (RT) alone for cancer patients of larynx, breast, blood and brain origins through complete blood count (CBC). Following were more depressed in CR patients: mean corpuscular hemoglobin-MCH & lymphocytes-LYM, hematocrit, mean corpuscular hemoglobin concentration-MCHC, hemoglobin-HB and red blood cells-RBC. In RT patients, following were more depressed: LYM, MCH and MCHC. Overall, in all cancer patients, the lymphocytes were depressed 52%. There existed a significant difference between white blood cells and RBC in both CR and RT patients. A significant moderate negative correlation is found in HB with the dose range 30-78 (Gray) given to the CR cancer patients. More number of CBC parameters affected in patients treated with CR and RT; but in less percentage as compared to patients who treated with RT alone. The cancer patients suffered from anemia along with immune modulations from the treatments.

(PDF emailed within 0-6 h: $19.90)

Accession: 058769447

Download citation: RISBibTeXText

PMID: 27423975

DOI: 10.1016/j.critrevonc.2016.06.001

Related references

Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping. International Journal of Radiation Oncology, Biology, Physics 80(3): 893-899, 2011

Review: various interventions prevent or reduce oral mucositis in patients with cancer receiving chemotherapy or radiotherapy. Evidence-Based Nursing 10(1): 13-13, 2007

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiotherapy & Oncology 66(3): 253-262, March, 2003

A comparison of two intravenous infusion devices in lung carcinoma patients receiving combined radiotherapy and chemotherapy. Journal of Cancer Research and Therapeutics 9(4): 664-667, 2014

Quality of life of cancer patients receiving chemotherapy and radiotherapy. Onkologie 9(3): 172-174, 177-180, 1986

Epoetin alfa (EPO) 60,000 U every 2 weeks (Q2W) in patients (pts) with cancer not receiving chemotherapy (CT) or radiotherapy (RT). Journal of Clinical Oncology 23(16_suppl): 8229-8229, 2016

Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis. Medicine 94(23): E879-E879, 2015

Pre-radiotherapy PSA level as a predictor for biochemical control in prostate cancer patients receiving radiotherapy after radical prostatectomy. Biomedical Journal 36(2): 71-76, 2013

Follow up of patients with lung cancer receiving radical radiotherapy: Continuous hyperfractionated accelerated radiotherapy (CHART) treatment. Lung Cancer 67: S29-S30, 2010

Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy. International Journal of Urology 14(7): 591-594, 2007

Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy. Strahlentherapie und Onkologie, 2018

Acute skin reactions in postoperative breast cancer patients receiving radiotherapy plus adjuvant chemotherapy. Ajr. American Journal of Roentgenology 130(1): 137-139, 1978

Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling. European Journal of Cancer Care 23(2): 249-254, 2015

Clinical predictors for reactive tube feeding in patients with advanced oropharynx cancer receiving radiotherapy ± chemotherapy. European Archives of Oto-Rhino-Laryngology 274(10): 3741-3749, 2017

Icelandic cancer patients receiving chemotherapy or radiotherapy: does distance from treatment center influence distress and coping?. Cancer Nursing 30(6): E1-10, 2007